Mainz Biomed receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Sep 16, 2026

Quantum Cyber N.V.

Nasdaq notified Mainz Biomed on Mar 20, 2026 that its share price closed below $1.00 for 30 consecutive business days through Mar 19, 2026.
Company has 180 calendar days, until Sep 16, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
If not cured by Sep 16, 2026, Mainz may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.
There can be no assurance of regaining compliance or avoiding delisting; the letter has no immediate impact on trading.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.